Anixa Biosciences Inc — Director's Dealing 2015

Jun 29, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ITUS Corp (ITUS)
CIK: 0000715446
Period of Report: 2015-06-25

Reporting Person: JOHNSON BRUCE F (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-25	Common Stock	P	210000	$0.1135	Acquired	9077167	Direct

Footnotes

F1: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.105 to $0.124, inclusive. The reporting person undertakes to provide to ITUS Corporation, any security holder of ITUS Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth.

F2: The number of shares shown are as of June 25, 2015 and do not reflect the reverse stock split effective June 26, 2015.